Sacituzumab govitecan

Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan shows anticancer activity.
Supplier Alfa Cytology
Product # PC0146
Pricing 1 mg, 5 mg,10 mg, 50 mg, inquire
Feedback